Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zymeworks Inc (NY: ZYME ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zymeworks Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Zymeworks Announces Participation in Upcoming Investor Conferences May 28, 2024 From Zymeworks Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm May 19, 2024 From Bragar Eagel & Squire Via GlobeNewswire Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME) May 16, 2024 From Kirby McInerney LLP Via Business Wire Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) May 07, 2024 Via Benzinga Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results May 02, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks Announces Participation in Upcoming Investor Conferences April 30, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 April 11, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting April 08, 2024 From Zymeworks Inc. Via GlobeNewswire ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm April 03, 2024 From Bragar Eagel & Squire Via GlobeNewswire Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME) April 02, 2024 From Kirby McInerney LLP Via GlobeNewswire Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors March 28, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks Announces Participation in Upcoming Investor Conferences March 27, 2024 From Zymeworks Inc. Via GlobeNewswire Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade March 08, 2024 Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care. Via InvestorPlace ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023 March 06, 2024 ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results March 06, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting March 05, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks Announces Participation in Upcoming Investor Conferences February 27, 2024 From Zymeworks Inc. Via GlobeNewswire Earnings Scheduled For March 6, 2024 March 06, 2024 Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. Via Benzinga 3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List February 22, 2024 Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price. Via InvestorPlace Last Call! 7 Small-Cap Stocks Ready to Explode in Value February 20, 2024 Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value. Via InvestorPlace Zymeworks - Analysts Project A Big Turnaround February 20, 2024 Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. Via Talk Markets 7 Small-Cap Stocks With Significant Upside Potential in 2024 February 15, 2024 Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on. Via InvestorPlace Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call February 14, 2024 From Zymeworks Inc. Via GlobeNewswire BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer February 09, 2024 Via Investor Brand Network Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors February 08, 2024 From Zymeworks Inc. Via GlobeNewswire 3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List February 06, 2024 These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. Via InvestorPlace 3 Top Stocks to Buy This Winter for Sizzling Summer Gains January 31, 2024 With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains. Via InvestorPlace Zymeworks Announces Participation in Upcoming Investor Conferences January 31, 2024 From Zymeworks Inc. Via GlobeNewswire A Look Into Healthcare Sector Value Stocks January 22, 2024 Via Benzinga Overview Of Value Stocks In The Healthcare Sector January 15, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.